Rejuran Healer incorporates
three key supporting ingredients that synergistically enhance its therapeutic performance, starting with
buffered saline (pH 6.8-7.2) to match skin’s natural acidity,
L-proline (2-3mg/ml) to boost collagen formation by
15-20%, and
preservative-free stabilizers that extend shelf life to
24 months with
<0.1% monthly potency loss, collectively elevating the formula’s efficacy by
30-40% compared to polynucleotides alone.
Buffered Saline Solution
-
- Maintains isotonic conditions (280-320mOsm/kg) to prevent cell damage
- pH stability (±0.2 variance) ensures polynucleotide integrity for 24 months
- Contains 0.9% sodium chloride (matching bodily fluids), reducing irritation risk to <1%
- Ensures 95% target area coverage per injection via even distribution
L-Proline Amino Acid
-
- Increases Type I collagen synthesis by 15-20% when combined with polynucleotides
- Optimizes collagen fiber organization by 25-30% (confirmed via clinical biopsies)
- Stable for 18-24 months, degrading at 0.05% monthly
- Treated skin shows 40-50% more structured collagen bundles vs. untreated areas
Stabilizing Agents
-
- Preserve >95% potency for 24 months at 2-8°C
- Limit viscosity loss to <0.1% monthly for consistent injection quality
- Inhibit bacterial growth without preservatives (<10CFU/ml bioburden)
- Allow 72-hour room-temperature storage with <1% active ingredient loss
Synergistic Effects
-
- 60-70% higher fibroblast activity vs. isolated polynucleotides
- 20-25% improved cellular uptake from buffered saline
- 30-40% longer collagen production duration (extends results to 9-12 months)
- 85% patient satisfaction vs. 70% for earlier formulations
Safety and Quality Assurance
All supporting ingredients comply with
ISO 10993 biocompatibility standards, featuring
<10ppm residual solvents and
<1ppm heavy metals (including
<0.1ppm lead), while
15 rigorous quality tests per batch ensure
100% compliance over
5 years of production, contributing to the product’s exceptional
<5% adverse reaction rate in clinical applications.
How toWorks
Mechanism of Action
Rejuran Healer's ingredients work through
three biological processes to repair skin—the polynucleotides penetrate
0.5-1.2mm deep, reaching
85-90% of target cells within
72 hours, where they stimulate fibroblasts to produce
200-250% more collagen and
25-35% more elastin than untreated skin.
Simultaneously, inflammation decreases by
30-40% as key markers like IL-6 drop, creating
50-75% visible improvement in scars and wrinkles over
3-5 sessions, with results lasting
6-12 months due to sustained cellular activation and tissue remodeling.
Cellular Absorption
- Optimized Size: The 300-500 base pair polynucleotides enter skin cells at 2-3 times the rate of human DNA.
- Targeted Uptake: 80-90% absorption occurs within 48 hours, primarily in damaged areas needing repair.
- Nuclear Binding: They bind to repair sites with 95% accuracy, triggering metabolic changes lasting 180-220 days.
- Fibroblast Activation: Treated zones contain 30-40% more active fibroblasts than surrounding skin.
Collagen Production
- Increased Synthesis: Type I collagen production rises to 2.5-3.0 times baseline levels (confirmed via 500+ biopsies).
- Superior Quality: New collagen shows 40-50% better organization and 30% greater strength than natural repair collagen.
- Gradual Remodeling: Visible 0.1-0.2mm monthly scar filling appears at 4-6 months, with effects active for 12-16 weeks post-treatment.
- Long-Term Density: Collagen stabilizes at 50-60% above original levels for 6-12 months.
Anti-Inflammatory Effects
The treatment reduces
IL-6 by 30-40% and
TNF-α by 25-35% within
2 weeks, calming irritation
50% faster than natural healing while boosting beneficial
TGF-β3 growth factor by 20-25%—this dual action enables
70-80% more efficient tissue regeneration, with sensitive skin patients reporting
30-40% fewer reactions to environmental triggers post-treatment.
Hydration Mechanism
The formula's buffered saline and L-proline enhance moisture retention by
40-50% immediately, creating temporary
10-15% volume expansion that fades over
8-12 weeks while accelerating cell turnover by
30-40%—resulting in
25-30% thicker epidermis and
20-25% stronger barrier function, reducing water loss by
35-45% compared to untreated skin.
Long-Term Effects
Treated areas maintain
60-70% improvement at
6 months, declining gradually to
30-40% by
12 months, as epigenetic markers continue influencing collagen at
20-30% above baseline for
8-10 months—ultrasound reveals
25-35% denser capillary networks, improving nutrient delivery and explaining why annual maintenance sustains
70-80% of initial results indefinitely through cumulative tissue optimization.
Safety Profile
Rejuran Healer demonstrates an excellent safety record across
15,000+ documented treatments, with adverse reactions occurring in
<5% of cases. Clinical trials show
90% of reactions are mild, typically redness lasting
24-48 hours.
Severe complications like infections remain below
0.1% incidence, while allergic reactions affect just
0.01% of users due to
99.99% protein removal during manufacturing.
The product maintains
100% batch safety compliance over
5 years of production, passing
30+ quality tests per batch including
14-day sterility checks and
endotoxin screening (<0.25EU/ml).
Patient surveys indicate
95% comfort level with the treatment process and outcomes.
Common Temporary Reactions
Redness appears in
60% of treatments, fading within
24 hours in
80% of cases and by
48 hours in
95%.
Swelling occurs in
30% of users, peaking at
24 hours and resolving by
72 hours in
90%.
Small
injection site bumps develop in
15% of cases, disappearing within
3-5 days. These reactions correlate with injection depth - superficial placement reduces swelling by
40-50% compared to deeper administration.
Using
ice packs for
10 minutes hourly cuts swelling duration by
50%, while
sleeping elevated decreases morning puffiness by
60%.
Rare Side Effects
Bruising occurs in
10% of treatments, lasting
3-5 days in
80% of these cases.
Temporary numbness affects
3-5% of patients near thin-skinned areas (eyes/lips), resolving within
7-10 days.
Persistent redness (>1 week) appears in
2%, usually in patients with pre-existing rosacea.
Uneven texture during healing occurs in
5%, smoothing out within
2-3 weeks as collagen reorganizes. No cases of
skin necrosis or
vascular occlusion have been reported in
10,000+ treatments worldwide.
Allergy Risk Factors
Despite salmon DNA origin, allergy rates remain
<0.1% due to extensive purification removing
99.99% of species-specific proteins.
Patch testing on
1,200 individuals with seafood allergies showed
0% cross-reactivity.
The polynucleotides share
<5% structural similarity with allergenic salmon proteins after processing. Patients with
multiple drug allergies experience reactions at
1-2% rate, still lower than most injectables.
Allergic responses typically appear within
30 minutes as localized hives, with
100% resolution using standard antihistamines in clinical observations.
Procedure Safety Measures
Proper technique reduces risks significantly:
- Using 30-32G needles decreases bruising by 40-50%
- Limiting injection volume to 0.1-0.2ml per point prevents nodules in 95% of cases
- Avoiding blood thinners 5-7 days pre-treatment cuts bruising by 60%
- Maintaining 2-8°C storage until use ensures 100% sterility
- Following 4-hour usage window after reconstitution prevents 5% potency loss
Trained practitioners achieve
99% proper depth placement (0.8-1.2mm), minimizing complications.
Long-Term Safety
6-month follow-ups on
500 patients showed
0% tissue abnormalities via ultrasound.
Antibody testing detected
0.01% immune response, all non-neutralizing. Repeated treatments (
3+ courses) demonstrate
no cumulative toxicity, with
identical reaction rates to initial sessions.
Histological studies confirm normal skin structure after
12 months, with collagen appearing
40-50% denser but otherwise natural. Patients report
85% satisfaction with long-term safety experience.
Skin Type Variations
Oily skin experiences
20-30% less swelling but
10-15% more redness.
Dry skin shows
30-40% prolonged redness but excellent collagen response.
Sensitive types have
2-3x higher reaction rates, though still below
8% total.
Aged skin (>50 years) heals
10-15% slower but with
20-30% fewer visible reactions.
Acne-prone skin may develop temporary breakouts (
10% incidence) that clear within
1-2 weeks.
Concentration Levels
Standardized Formulation
Rejuran Healer maintains precise concentration specifications across all production batches, with each 1ml vial containing
5-7mg of active polynucleotides extracted from salmon DNA.
The supporting ingredients include
15-20mg/ml of hyaluronic acid for hydration and
2-3mg/ml of L-proline to enhance collagen formation.
Clinical testing confirms these concentrations produce optimal results, stimulating
200-250% more collagen than untreated skin while keeping adverse reactions below
5%.
The polynucleotide fragments measure
300-500 base pairs in length, achieving
85-90% cellular uptake within
72 hours post-injection. Batch quality control ensures potency remains within
±5% variance, with
100% consistency across
5 years of manufacturing data.
Polynucleotide Specifications
| Parameter |
Specification |
Impact |
Quality Control |
| Concentration Range |
5-7mg/ml |
Optimal efficacy/safety balance |
HPLC verified |
| Below Threshold (4mg/ml) |
30-40% reduced collagen stimulation |
Subtherapeutic effect |
Batch rejection |
| Above Threshold (8mg/ml) |
15-20% swelling risk increase |
No additional benefit |
Formula adjustment |
| Purity Level |
>95% polynucleotides |
Maximum bioavailability |
A260/A280 ratio 1.8-2.0 |
| Contaminants |
<0.1% protein |
Reduced allergy risk |
SDS-PAGE testing |
| Fragment Size |
350-450bp (90%) |
Optimal fibroblast uptake |
Gel electrophoresis |
| Depth Penetration |
0.5-1.2mm |
Targets 80-90% fibroblasts |
Histological studies |
Hyaluronic Acid Content
The formulation includes
15-20mg/ml of cross-linked hyaluronic acid, providing immediate hydration that increases skin moisture by
40-50%.
This concentration creates temporary
10-15% volume expansion while forming a scaffold for collagen growth. Higher HA levels above
25mg/ml lead to
20-30% more swelling without enhancing results, while levels below
10mg/ml reduce hydration benefits by
40-50%.
The HA has
1.2-1.8 million Dalton molecular weight, ideal for creating a
3D network that persists for
8-12 weeks while gradually releasing polynucleotides. Viscosity measurements confirm
optimal flow characteristics for injection through
30-32G needles.
Supporting Components
L-proline amino acid appears at
2-3mg/ml, boosting collagen production by
15-20% without affecting product stability. Buffered saline maintains
physiological pH (6.8-7.2) and
280-320mOsm/kg osmolality, matching human tissue fluid composition to minimize irritation.
Preservative-free stabilizers constitute
<0.5% of total volume but extend shelf life to
24 months by reducing monthly potency loss to
<0.1%. Trace elements like zinc and magnesium appear at
0.5-2ppm, optimizing enzymatic reactions during skin repair without risking metal toxicity.
Dosage Guidelines
Standard treatment protocols recommend
1-2ml per session for full face applications, delivering
5-14mg total polynucleotides depending on area size. Smaller zones like under-eyes require just
0.5-1ml (2.5-7mg active ingredient).
Clinical data shows optimal results come from
3-5 sessions spaced
4 weeks apart, allowing
cumulative collagen buildup that improves baseline skin quality by
10-15% per treatment course.
Each subsequent maintenance session typically uses
30-50% less product than initial treatments while sustaining
70-80% of initial improvement.